These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2048219)

  • 21. [Is cholecystokinin a biological support in panic attacks?].
    Bourin M; Bradwejn J; Koszycki D
    Encephale; 1991; 17(5):475-9. PubMed ID: 1686250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholecystokinin and thermoregulation--a minireview.
    Szelényi Z
    Peptides; 2001 Aug; 22(8):1245-50. PubMed ID: 11457517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CCKA and CCKB receptor subtypes both mediate the effects of CCK-8 on myenteric neurons in the guinea-pig ileum.
    Schutte IW; Akkermans LM; Kroese AB
    J Auton Nerv Syst; 1997 Dec; 67(1-2):51-9. PubMed ID: 9470144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dissociated high-purity dopaminergic neuron cultures from the substantia nigra and the ventral tegmental area of the postnatal rat.
    Masuko S; Nakajima S; Nakajima Y
    Neuroscience; 1992 Jul; 49(2):347-64. PubMed ID: 1359454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electrophysiological effects of cholecystokinin: central dopaminergic systems.
    Wang RY; White FJ
    Prog Clin Biol Res; 1985; 192():95-103. PubMed ID: 4080721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mediation by CCKB receptors of the CCK-evoked hyperaemia in rat gastric mucosa.
    Heinemann A; Jocic M; Holzer-Petsche U; Pethö G; Peskar BM; Horwell DC; Holzer P
    Br J Pharmacol; 1995 Oct; 116(4):2274-8. PubMed ID: 8564259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of cholecystokinin-A and cholecystokinin-B receptors in anxiety.
    Hernandez-Gómez AM; Aguilar-Roblero R; Pérez de la Mora M
    Amino Acids; 2002; 23(1-3):283-90. PubMed ID: 12373548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholecystokinin: Corelease with dopamine from nigrostriatal neurons in the cat.
    Artaud F; Baruch P; Stutzmann JM; Saffroy M; Godeheu G; Barbeito L; Hervé D; Studler JM; Glowinski J; Chéramy A
    Eur J Neurosci; 1989 Mar; 1(2):162-171. PubMed ID: 12106166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Release of cholecystokinin in the central nervous system.
    Raiteri M; Paudice P; Vallebuona F
    Neurochem Int; 1993 Jun; 22(6):519-27. PubMed ID: 8513278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Receptor selectivity of cholecystokinin effects on mesoaccumbens dopamine neurons.
    Kelland MD; Zhang J; Chiodo LA; Freeman AS
    Synapse; 1991 Jun; 8(2):137-43. PubMed ID: 1882334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CCKB receptors mediate CCK-8S-induced activation of dorsal hippocampus CA3 pyramidal neurons: an in vivo electrophysiological study in the rat.
    Gronier B; Debonnel G
    Synapse; 1995 Oct; 21(2):158-68. PubMed ID: 8584977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antipsychotic potential of CCK-based treatments: an assessment using the prepulse inhibition model of psychosis.
    Feifel D; Reza T; Robeck S
    Neuropsychopharmacology; 1999 Feb; 20(2):141-9. PubMed ID: 9885794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Substance P and cholecystokinin regulate neurochemical responses to cocaine and methamphetamine in the striatum.
    Loonam TM; Noailles PA; Yu J; Zhu JP; Angulo JA
    Life Sci; 2003 Jun; 73(6):727-39. PubMed ID: 12801594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholecystokinin-Mediated Neuromodulation of Anxiety and Schizophrenia: A "Dimmer-Switch" Hypothesis.
    Ballaz SJ; Bourin M
    Curr Neuropharmacol; 2021; 19(7):925-938. PubMed ID: 33185164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antagonism of cholecystokinin function in the rostral and caudal nucleus accumbens: differential effects on brain stimulation reward.
    Vaccarino FJ; Vaccarino AL
    Neurosci Lett; 1989 Feb; 97(1-2):151-6. PubMed ID: 2918999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CCK, schizophrenia, and anxiety. CCK-B antagonists inhibit the activity of brain dopamine neurons.
    Rasmussen K
    Ann N Y Acad Sci; 1994 Mar; 713():300-11. PubMed ID: 8185172
    [No Abstract]   [Full Text] [Related]  

  • 37. Neurobiology of cholecystokinin.
    Moran TH; Schwartz GJ
    Crit Rev Neurobiol; 1994; 9(1):1-28. PubMed ID: 8828002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for the contribution of CCKB receptor mechanisms to individual differences in amphetamine-induced locomotion.
    Higgins GA; Sills TL; Tomkins DM; Sellers EM; Vaccarino FJ
    Pharmacol Biochem Behav; 1994 Aug; 48(4):1019-24. PubMed ID: 7972279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine- and cholecystokinin-containing neurons of the crossed mesostriatal projection.
    Fallon JH; Wang C; Kim Y; Canepa N; Loughlin S; Seroogy K
    Neurosci Lett; 1983 Oct; 40(3):233-8. PubMed ID: 6316210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Several roles of CCKA and CCKB receptor subtypes in CCK-8-induced and LiCl-induced taste aversion conditioning.
    Mosher JT; Johnson MF; Birkemo LS; Ervin GN
    Peptides; 1996; 17(3):483-8. PubMed ID: 8735976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.